Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Report, "Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Graves Diseases Report is to understand the market and pipeline status of the drugs around the Graves Diseases to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Graves Diseases. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Scope:

- A snapshot of the global Market and Phase III therapeutics scenario for Graves Diseases.

- A review of the marketed products under prescription for Graves Diseases, regulatory information and marketing status.

- Coverage of global patent coverage and detailed commentaries on the US patent challenges.

- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

- Product profiles for marketed products for Graves Diseases with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

- Coverage of API Manufacturers for Graves Diseases drugs in the United States, Europe and Asian Regions with location details.

- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Graves Diseases drugs.

- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Graves Diseases drugs.

- Coverage of Graves Diseases Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

- Key discontinued Marketed products.

- Global Sales Figure to 2018.

Reasons to buy

- Evaluate the marketing status and exclusivity details of Graves Diseases key products to exploit opportunities for generic drug development opportunities.

- Identify and understand important and diverse types of therapeutics under Phase III development for Graves Diseases.

- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Graves Diseases.

- API intelligence over marketed drugs for Graves Diseases and gaining primary intelligence over active ingredients manufacturers across the globe.

- API intelligence over leading Phase III Pipeline drugs.

- Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

- Understanding the scope of the Phase III Drugs with nil regulatory filings.

- Understanding the chemical route of synthesis of approved drugs for Graves Diseases.

- Uncovering opportunities in the rapidly growing US market.

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Table of Contents

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Graves Diseases
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Graves Diseases
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Graves Diseases
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

Graves Diseases Therapeutic Market, US, Marketed Drugs by Application Type, 2016
Graves Diseases Therapeutic Market, US, Marketed Drugs by Marketing Status, 2016
Graves Diseases Therapeutic Market, US, (Year), 2016
Graves Diseases Marketed Drugs, API Manufacturers by US DMF Status, 2016
Graves Diseases Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Graves Diseases Drugs, API Manufacturers, Europe by Country, 2016
Graves Diseases Drugs, API Manufacturers, India by State, 2016
Graves Diseases Drugs, API Manufacturers, China by Province, 2016
Graves Diseases Drugs, API Manufacturers by Geography 2016
Graves Diseases Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Graves Diseases Therapeutic Market, Global Sales-2018 (in million USD)
API Manufacturers for Drug, 2016
Phase III Drugs for Graves Diseases, 2016
Discontinued Drugs for Graves Diseases, 2016

List of Figures

Graves Diseases Therapeutic Market, US, Marketed Drugs by Application Type (%), 2016
Graves Diseases Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2016
Graves Diseases Therapeutic Market, US, (Year), 2016
Graves Diseases Marketed Drugs, API Manufacturers by US DMF Status (%), 2016
Graves Diseases Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Graves Diseases Drugs, API Manufacturers, Europe by Country, 2016
Graves Diseases Drugs, API Manufacturers, India by State, 2016
Graves Diseases Drugs, API Manufacturers, China by Province, 2016
Graves Diseases Drugs, API Manufacturers by Geography 2016
Graves Diseases Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Graves Diseases Therapeutic Market, Global Sales 2018 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2016
  • Systemic Lupus Erythematosus - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 419
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. The inflammation triggered by SLE affect many organs in the body, including skin, joints, kidneys, brain, and other organs. Several factors have been associated ......
  • Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020
    Published: 03-Nov-2016        Price: US 2500 Onwards        Pages: 98
    Immunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet need in the autoimmune and inflammatory immunomodulators market as there are no medicines that provide complete cure to some diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease. This analyst forecast the global auto......
  • Global Autoimmune Partnering 2010-2016: Deal trends, players and financials
    Published: 01-Nov-2016        Price: US 2995 Onwards        Pages: 700
    "Delivery of this report will take 1-3 days after purchase." Global Autoimmune Partnering 2010 to 2016 provides the full collection of Autoimmune disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Autoimmune partnering deals Financial deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement structure Autoimmune partnering contract ......
  • Graves Disease  - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Nov-2016        Price: US 4950 Onwards        Pages: 100
    DelveInsight's Graves Disease - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Graves Disease for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Graves Disease forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also......
  • Enbrel -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Enbrel- Drug Insights, 2016" highlights the Enbrel marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Enbrel covering the total sales estimation and also provides the Enbrel sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Enbrel, patents information and exclusivity......
  • Celiac Disease-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Celiac Disease-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Celiac Disease. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions,......
  • Graves Disease  - Epidemiology Forecast To 2023
    Published: 01-Nov-2016        Price: US 2750 Onwards        Pages: 60
    DelveInsight "Graves Disease - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Graves Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Graves Disease prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Grav......
  • Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2016
    Published: 20-Jul-2016        Price: US 2000 Onwards        Pages: 47
    Global Markets Direct's, ‘Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2016', provides an overview of the Microscopic Polyangiitis (MPA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Microscopic Polyangiitis (MPA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action o......
  • Primary Biliary Cirrhosis - Pipeline Review, H2 2016
    Published: 13-Jul-2016        Price: US 2000 Onwards        Pages: 90
    Global Markets Direct's, ‘Primary Biliary Cirrhosis - Pipeline Review, H2 2016', provides an overview of the Primary Biliary Cirrhosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Biliary Cirrhosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeut......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs